Kids who discontinue pump therapy become “less adherent” and achieve poorer BG results than kids who remain on the pump, according to Joslin researchers who followed a group of type 1 youth starting the pump between 1998 and 2001.
When starting pump therapy, patients had an average age of 14.1 years and diabetes duration of 7.1 years. As of 2005, 18 percent of the patients had resumed injection therapy. The researchers note that blood-glucose-monitoring frequency at the start and at one year was significantly lower in the patients who resumed injection therapy.
“In addition, patients who remained on the pump had lower A1Cs than those who resumed injection therapy at both one year and at the most recent clinic visit.”
Diabetes Care, November 2006